Hormones that make weight loss harder (thyroid, PCOS, cortisol)

The handicap is real. It is measured in kilograms, not in whole diets.#

Thyroid disease, PCOS and cortisol excess all make weight loss harder, and every one of them has now been measured against a control group rather than described. When you put numbers on them, the pattern is consistent: the conditions change the difficulty, the timeline and the medical workup, and none of them removes the effect of an energy deficit. The professional body for thyroid disease puts the weight attributable to hypothyroidism at about 5–10 pounds and notes that "most of the weight gained is actually due to retaining salt and water"⁵. Women with PCOS and obesity, given the same six-month lifestyle program as matched women without PCOS, lost the same amount.

That is not a dismissal. A person with untreated hypothyroidism, or PCOS with marked insulin resistance, or someone on long-term steroids, is running the same deficit arithmetic with worse fatigue, worse appetite regulation and a smaller margin for error. The point of putting numbers on it is to know how much of a stall a diagnosis can honestly account for — because in most cases the answer is: some of it, not all of it, and rarely the part that has been flat for three months.

Thyroid: the dose experiment nobody expected#

The most decisive thyroid evidence is a randomized, double-blind trial that did the thing observational studies can't: it deliberately moved people's thyroid status. 138 adults on levothyroxine were randomized for six months to target a low-normal TSH (0.34–2.50 mU/L), a high-normal TSH (2.51–5.60), or a mildly elevated one (5.61–12.0), with final doses differing nearly twofold (1.50 vs 1.32 vs 0.78 µg/kg, P < 0.001). There were no substantial differences among the arms in resting energy expenditure, total energy expenditure or the thermic effect of food, and none in fat mass, lean mass, BMI or visceral fat¹.

The nuance is in the continuous analysis, where resting expenditure per unit of lean mass did move inversely with TSH (P = 0.001) and directly with free T4 (P = 0.01). So the relationship exists — it is simply too small to produce a measurable difference in body composition over half a year, across a TSH range wide enough to include values most people would call "a thyroid problem."

Overt, untreated hypothyroidism is a different situation and is a genuine medical cause of weight gain — which is exactly why it is worth diagnosing. But the expectation set by the internet is wrong in a specific way: treatment returns weight to roughly where it was before the hypothyroidism started, and much of what comes off is fluid rather than fat. Thyroid hormone is not a fat-loss drug, and taking extra in the hope that it is buys insomnia, palpitations and loss of muscle mass. The broader relationship between thyroid function and metabolic rate is real; the fat-loss lever people hope for is not there.

The TSH result may be a consequence, not a cause#

Here is the interpretive trap. Adipose tissue makes leptin, and leptin drives the hypothalamic-pituitary-thyroid axis upward: as one review of the field puts it, "overnutrition, through hyperleptinemia, activates TRH expression and then synthesis of thyrotropin"⁴. The same review is candid that decades of work have not settled the direction: whether thyroid dysfunction is the cause or the consequence of excess adipose tissue "remains unclear."

What follows practically is narrow but useful. A mildly raised TSH in someone carrying extra weight is a finding that needs a clinician, not a diagnosis of why the scale stopped — because the same number is produced by the adiposity itself. It is the same category error as concluding from high leptin that the fullness signal has broken: the hormone is downstream of the fat, and reading it as upstream reverses the arrow.

PCOS: the same intervention, the same result#

PCOS is where the "hormones make it impossible" claim is most common and most testable, because you can put women with and without it through an identical program. In a post hoc analysis of a randomized trial, 87 women with PCOS and obesity and 172 women with obesity but no PCOS completed the same six-month lifestyle intervention — roughly a 600 kcal/day restriction plus moderate activity and counselling. BMI fell significantly in both groups, and the between-group difference was not significant at three months (adjusted B −0.3, P = 0.35) or six months (adjusted B 0.5, P = 0.29). Dropout was 24.7% versus 20.4% (P = 0.40). The authors concluded that current weight-management recommendations for the general population can be applied to women with PCOS².

One caveat worth stating: these were infertile women in a fertility-focused trial, so they were unusually motivated, and the analysis was post hoc. But it is a direct comparison under a common protocol, which is precisely what the folk claim predicts should fail — and it didn't.

What is different in PCOS is what each kilogram buys. Weight loss in PCOS improves androgen markers, insulin sensitivity and reproductive outcomes to a degree it doesn't in someone without the syndrome. The insulin resistance is a real clinical problem; it is just not an energy-expenditure problem large enough to explain a stalled month.

Cortisol, at the dose a prescription actually delivers#

Most people invoking cortisol mean stress. The stronger test is people taking pharmacological glucocorticoids, where the exposure is unambiguous and sustained. In a population cohort of 31,516 adults prescribed systemic glucocorticoids at ≥10 mg/day for at least three months, against 26,967 controls: 39.6% gained more than 2 kg, and 10.2% gained 10% or more of their usual weight. In the most susceptible group — women aged 18–39 — mean gain was 3.6 kg versus 2.0 kg in controls, an absolute difference of 1.6 kg (95% CI 0.9 to 2.2, P < 0.001). The authors' own summary is that glucocorticoid-induced weight gain is "less than usually thought"³.

Hold that next to the folk version. A genuine, prescribed, months-long cortisol excess — far beyond anything a stressful job produces — moved the average by a couple of kilograms, with a tenth of patients experiencing something dramatic. At true disease doses the effect on where fat sits is much larger, which is the real basis for every "cortisol belly" claim, but that is a clinical syndrome with other unmistakable signs, not an explanation for an ordinary plateau.

What a diagnosis actually changes about your plan#

If you have one of these conditions, four things follow, and none of them is "energy balance doesn't apply to me."

1. Get it treated on its own merits. Untreated hypothyroidism, uncontrolled PCOS and unnecessary steroid exposure are worth fixing for health reasons that have nothing to do with the scale. Expect the weight benefit to be modest and largely fluid.
2. Widen your review window, don't deepen your deficit. Fatigue and appetite dysregulation make execution less consistent, which shows up as noisier weekly averages, not a smaller deficit. Judge four weeks, not two.
3. Derive your maintenance from your own data. Prediction equations were not built for these populations, so back-calculating maintenance from a logged intake and a weight trend is more reliable than any calculator's guess about your hormones.
4. Rule out the ordinary causes first anyway. The common reasons a deficit closes — intake drifting up, maintenance falling with bodyweight — do not exempt anyone. A hormone diagnosis makes them more likely to be missed, not less likely to be true.

FAQ#

Can a thyroid problem stop you from losing weight completely?#

No evidence supports that. In a six-month randomized trial that deliberately varied levothyroxine dose across a wide TSH range, there were no substantial differences in energy expenditure or body composition between arms. Untreated overt hypothyroidism genuinely adds weight — on the order of 5–10 pounds, much of it salt and water — and slows you down, but it doesn't neutralize a deficit.

Does PCOS make you lose weight more slowly than other people?#

Not in the one comparison that put both groups through the same program. 87 women with PCOS and obesity and 172 without PCOS did an identical six-month intervention, and BMI change did not differ significantly at three or six months, with similar dropout. What differs is the payoff: the same weight loss improves androgen and reproductive markers in PCOS in ways it can't for someone without it.

Will treating hypothyroidism make the weight come off?#

Some of it, and less than you're hoping. Treatment returns body weight roughly to where it was before the hypothyroidism began, and a large share of what leaves is retained salt and water rather than fat. Deliberately over-replacing to lose more is not a strategy — it costs muscle mass, sleep and heart rhythm, and the weight returns when the excess dose stops.

Sources#

1. Samuels MH, Kolobova I, Niederhausen M, Purnell JQ, Schuff KG. Effects of altering levothyroxine dose on energy expenditure and body composition in subjects treated with LT4. J Clin Endocrinol Metab. 2018
2. Wang Z, Groen H, Cantineau AEP, et al. Effectiveness of a 6-month lifestyle intervention in women with PCOS and obesity and non-PCOS obese controls: one size fits all? Nutrients. 2021
3. Fardet L, Nazareth I, Petersen I. Long-term systemic glucocorticoid therapy and weight gain: a population-based cohort study. Rheumatology (Oxford). 2021
4. Walczak K, Sieminska L. Obesity and thyroid axis. Int J Environ Res Public Health. 2021
5. American Thyroid Association. Thyroid and Weight.